2-(3,4-DiMethoxyphenyl)-6-ethyl-3-hydroxychroMen-4-one
|
- $265 - $917
- Product name: 2-(3,4-DiMethoxyphenyl)-6-ethyl-3-hydroxychroMen-4-one
- CAS: 1365271-38-0
- MF: C19H18O5
- MW: 326.34
- EINECS:
- MDL Number:MFCD21609686
- Synonyms:2-(3,4-DiMethoxyphenyl)-6-ethyl-3-hydroxychroMen-4-one;4H-1-Benzopyran-4-one, 2-(3,4-dimethoxyphenyl)-6-ethyl-3-hydroxy-
4 prices
Selected condition：
Brand
- AK Scientific
- Chemenu
- Crysdot
- TRC
Package
- 100mg
- 1g
- ManufacturerAK Scientific
- Product numberV2546
- Product description2-(3,4-Dimethoxyphenyl)-6-ethyl-3-hydroxychromen-4-one
- Packaging1g
- Price$917
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM284502
- Product description2-(3,4-Dimethoxyphenyl)-6-ethyl-3-hydroxychromen-4-one 95%
- Packaging1g
- Price$578
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11271820
- Product description2-(3,4-Dimethoxyphenyl)-6-ethyl-3-hydroxychromen-4-one 95+%
- Packaging1g
- Price$612
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberD562138
- Product description2-(3,4-Dimethoxyphenyl)-6-ethyl-3-hydroxychromen-4-one
- Packaging100mg
- Price$265
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | V2546 | 2-(3,4-Dimethoxyphenyl)-6-ethyl-3-hydroxychromen-4-one | 1g | $917 | 2021-12-16 | Buy |
| Chemenu | CM284502 | 2-(3,4-Dimethoxyphenyl)-6-ethyl-3-hydroxychromen-4-one 95% | 1g | $578 | 2021-12-16 | Buy |
| Crysdot | CD11271820 | 2-(3,4-Dimethoxyphenyl)-6-ethyl-3-hydroxychromen-4-one 95+% | 1g | $612 | 2021-12-16 | Buy |
| TRC | D562138 | 2-(3,4-Dimethoxyphenyl)-6-ethyl-3-hydroxychromen-4-one | 100mg | $265 | 2021-12-16 | Buy |
Properties
Boiling point :485.0±45.0 °C(Predicted)
Density :1.279±0.06 g/cm3(Predicted)
pka :8.66±0.20(Predicted)
Density :1.279±0.06 g/cm3(Predicted)
pka :8.66±0.20(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|